Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
44,469,174
-
Shares change
-
+708,171
-
Total reported value, excl. options
-
$506,043,282
-
Value change
-
+$8,118,835
-
Put/Call ratio
-
9.1%
-
Number of buys
-
71
-
Number of sells
-
-42
-
Price
-
$11.38
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2019
155 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2019.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,469,174 shares
of 119,358,581 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9,266,237 shares), VANGUARD GROUP INC (4,311,441 shares), BVF INC/IL (4,165,558 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2,720,165 shares), WASATCH ADVISORS INC (2,461,526 shares), STATE STREET CORP (2,320,879 shares), MILLENNIUM MANAGEMENT LLC (1,993,018 shares), Foresite Capital Management IV, LLC (1,898,970 shares), FMR LLC (1,682,871 shares), and FEDERATED INVESTORS INC /PA/ (930,927 shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.